Related Experiment Video
Updated: Aug 17, 2026
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
[Retinopathy of prematurity: screening and therapeutic indications]
Simona Tălu1, Gabriela Zaharia, Gabriela Vasile
1Clinica de Oftalmologie, UMF Iuliu Hatieganu, Cluj-Napoca.
Insights
Retinopathy of prematurity is a serious eye disease in premature infants. Improved neonatal care has increased its prevalence, necessitating better screening and treatment strategies for affected babies.
Area of Science:
- Ophthalmology
- Neonatology
- Vascular Biology
Context:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Advances in neonatal intensive care have led to increased survival rates of extremely premature infants, making ROP a growing concern.
- This condition affects the developing retinal blood vessels in preterm babies.
Purpose:
- To provide a comprehensive overview of retinopathy of prematurity.
- To discuss the underlying causes, risk factors, and classification systems for ROP.
- To highlight current screening protocols and therapeutic interventions for ROP.
Summary:
- ROP is a proliferative disorder of retinal blood vessels in premature infants.
- The paper details the pathogenesis, risk factors, and diagnostic criteria for ROP.
- Key screening and treatment methods for managing ROP are extensively discussed.
Impact:
- Enhanced understanding of ROP for neonatologists and ophthalmologists.
- Improved diagnostic and therapeutic strategies for retinopathy of prematurity.
- Potential for reducing visual impairment and blindness in premature infants due to ROP.
Abstract:
The retinopathy of prematurity is a proliferative disease of the retinal blood vessels, occurring in the prematurely born babies. As the life support conditions for the prematurely born babies have improved, the retinopathy of prematurity has became a problem, both for the neonatologists and the ophthalmologists. This paper discusses the pathogeny, the risk factors, the classification criteria and especially the methods for the screening and therapy of this disease.
